MRFF: 2020 Targeted translation research accelerator

The aim of this opportunity is to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease


Up to $47M.

Submission requirements & due date

Further information

Need help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, Major National Competitive Grants (Cat 1). Bookmark the permalink.

Comments are closed.